Sec. 5. Annual report

1,087 words·~5 min read·/bill/113/hr/3177/ih/section-5

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 104A(f) of the Foreign Assistance Act of 1961 ( 22 U.S.C. 2151b–2(f) ) is amended to read as follows: Not later than February 15, 2014, and annually thereafter, the President shall submit to the Committee on Foreign Relations of the Senate and the Committee on Foreign Affairs of the House of Representatives a report in an open, machine readable format, on the implementation of this section for the prior fiscal year. Each report submitted after February 15, 2014, shall include the following:

A description based on internationally available data, using high-quality country-based data where practicable, of the total global burden and need for HIV/AIDS prevention, treatment, and care, including— estimates by partner country of the global burden and need; and HIV incidence, prevalence, and AIDS deaths for the reporting period. Reporting on targets across prevention, treatment, and care interventions in partner countries, including— a description of how those targets are designed to— ensure that the annual increase in new patients on antiretroviral treatment exceeds the number of annual new HIV infections; reduce the number of new HIV infections so that it falls below number of deaths among persons infected with HIV; and achieve an AIDS-free generation; national targets across prevention, treatment, and care that are— established by partner countries; or where such national partner country-developed targets are unavailable, a description of progress towards developing national partner country targets; and bilateral programmatic targets across prevention, treatment, and care, including— the number of adults and children to be directly supported on HIV treatment under this section; the number of adults and children to be otherwise supported on HIV treatment under this section; and other programmatic targets for activities directly and otherwise supported by United States-funded programs.

A description, by partner country, of HIV/AIDS funding from all sources, including funding levels from partner countries, other donors, and the private sector, as practicable. A description of how United States bilateral programs, in conjunction with the Global Fund, other donors, and partner countries together set targets, measure progress, and achieve positive outcomes in partner countries. An annual assessment of outcome indicator development, dissemination, and performance for programs supported under this section, including ongoing corrective actions to improve reporting.

A description and explanation of changes in related guidance or policies related to implementation of programs supported under this section. An assessment and quantification of progress over the reporting period toward achieving the targets described in subparagraph (B), including— the number, by partner country, of persons on HIV treatment, including specifically— the number of adults and children on HIV treatment directly supported by United States-funded programs; the number of adults and children on HIV treatment otherwise supported by United States-funded programs;

HIV treatment coverage rates by country; the net increase in persons on HIV treatment by partner country; new infections of HIV by country; the number of HIV infections averted; antiretroviral treatment program retention rates, by partner country, including— performance against annual targets for program retention; and the retention rate of persons on HIV treatment directly supported by United States-funded programs; and a description of supportive care, including management of co-morbidities.

A description of partner country and United States-funded HIV/AIDS prevention programs and policies, including— an assessment, by partner country, of progress to achieve the targets described in subparagraph (B), with a detailed description of the metrics used to assess— programs to prevent mother to child transmission of HIV/AIDS, including coverage rates; programs to provide or promote voluntary medical male circumcision, including coverage rates; programs for behavior-change; and other programmatic activities to prevent the transmission of HIV; a description of antiretroviral treatment as prevention; and a description of any new preventative interventions or methodologies.

A description of the goals, scope, and measurement of program efforts aimed at women and girls. A description of the goals, scope, and measurement of program efforts aimed at orphans, vulnerable children, and youth. A description of the indicators and milestones used to assess effective, strategic, and appropriately timed partner country ownership, including— an explanation of the metrics used to determine whether the pace of any transition to such ownership is appropriate for such partner country, given that country’s level of readiness for such transition; an analysis of governmental and local nongovernmental capacity to sustain positive outcomes; a description of measures taken to improve partner country capacity to sustain positive outcomes where needed; and for partner countries undergoing a transition to greater country ownership, a description of strategies to assess and mitigate programmatic and financial risk to ensure continued quality of care for essential services.

A description, globally and by partner country, of specific efforts to achieve and incentivize greater programmatic and cost effectiveness, including— progress toward establishing common economic metrics across prevention, care and treatment with partner counties and the Global Fund; average costs, by partner country and by core intervention; expenditure reporting in all program areas, supplemented with targeted analyses of the cost-effectiveness of specific interventions; and import duties and internal taxes imposed on program commodities and services, by partner country.

A description of partnership framework agreements with countries and regions, where applicable, including— the objectives and structures of such agreements, including— how such agreements are aligned with national HIV/AIDS plans, public health strategies, and commitments of such countries and regions; and how such agreements incorporate a role for civil society; and what has been learned in advancing partnership framework agreements with countries, and regions as applicable, in terms of improved coordination and collaboration, definition of clear roles and responsibilities and implications for how to further strengthen these agreements with mutually accountable measures of progress.

A description of efforts and activities to engage new partners, including faith-based, community-based, and United States minority-serving institutions. A definition and description of the differentiation between directly and otherwise supported activities, including specific efforts to clarify programmatic attribution and contribution, as well as timelines for dissemination and implementation. In this subsection, the term partner country means a country that received not less than $5,000,000 in United States HIV/AIDS assistance under this section during the immediately preceding fiscal year. .

The annual report required to be submitted by not later than February 15, 2014, to the Committee on Foreign Relations of the Senate and the Committee on Foreign Affairs of the House of Representatives under section 104A(f) of the Foreign Assistance Act of 1961, as amended by subsection

(a)of this section, shall include the report elements contained in paragraph

(2)of such section 104A(f) as such section was in effect on the day before the date of the enactment of this Act.

Connections1 off-index

1 reference not yet in our index

22 USC 2151b–2(f)

Citation graph

cites case law

Sec. 5

Annual report

Cite22 USC 2151b–2(f)

Cites 1Cited by 0 across 0 sources